• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性尿毒症中不依赖于血压的血管结构变化。

Changes of vascular architecture independent of blood pressure in experimental uremia.

作者信息

Amann K, Neusüss R, Ritz E, Irzyniec T, Wiest G, Mall G

机构信息

Department of Pathology, University of Heidelberg, Germany.

出版信息

Am J Hypertens. 1995 Apr;8(4 Pt 1):409-17. doi: 10.1016/0895-7061(94)00248-a.

DOI:10.1016/0895-7061(94)00248-a
PMID:7619355
Abstract

Striking alterations of the structure of arterial vessels of different caliber are a well-known feature of renal failure, but it is currently unknown to what extent they are a reflection of hypertension or of uremia per se. To address this issue further we studied subtotally nephrectomized rats, sham-operated and pair-fed with matched controls. After uremia of 14 days' duration, stereologic measurements were carried out on perfusion-fixed tissue. To eliminate a potential influence of hypertension, subgroups of animals received furosemide and hydralazine in the drinking fluid to yield daily doses of 15 mg/kg and 20 mg/kg, respectively. At the end of the experiment, systolic blood pressure (tail plethysmography) was 110 +/- 13.3 (mean +/- SD) mm Hg and 99.4 +/- 8.1 mm Hg in untreated and treated controls, respectively, and 132 +/- 20.7 mm Hg and 103 +/- 13.0 mm Hg in untreated and treated uremic animals, respectively (n = 5 to 10 animals per group). The wall:lumen ratio of intramyocardial small arteries was 0.056 +/- 0.011 and 0.052 +/- 0.006 in untreated and treated controls, respectively. In untreated and treated uremic animals, the corresponding values were 0.077 +/- 0.011 and 0.066 +/- 0.007 (P < .01; control v uremia, ANOVA). A similar increase, unaffected by blood pressure treatment, was found for wall thickness of intramyocardial arteries. Analogous changes were also noted in mesenteric arterioles and veins. Finally, aorta media thickness was significantly (P < .005) higher in uremic animals than in controls (138 +/- 29 micrometers v 103 +/- micrometers).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

不同管径动脉血管结构的显著改变是肾衰竭的一个众所周知的特征,但目前尚不清楚它们在多大程度上反映了高血压或尿毒症本身。为了进一步解决这个问题,我们研究了接受次全肾切除术的大鼠,这些大鼠接受了假手术并与匹配的对照动物进行配对喂养。在持续14天的尿毒症期后,对灌注固定的组织进行了体视学测量。为了消除高血压的潜在影响,动物亚组在饮水中分别给予呋塞米和肼屈嗪,每日剂量分别为15mg/kg和20mg/kg。实验结束时,未治疗和治疗的对照动物的收缩压(尾容积描记法)分别为110±13.3(平均值±标准差)mmHg和99.4±8.1mmHg,未治疗和治疗的尿毒症动物分别为132±20.7mmHg和103±13.0mmHg(每组n = 5至10只动物)。未治疗和治疗的对照动物心肌内小动脉的壁腔比分别为0.056±0.011和0.052±0.006。在未治疗和治疗的尿毒症动物中,相应的值分别为0.077±0.011和0.066±0.007(P <.01;对照与尿毒症,方差分析)。心肌内动脉壁厚度也有类似的增加,不受血压治疗的影响。在肠系膜小动脉和静脉中也观察到类似变化。最后,尿毒症动物的主动脉中膜厚度显著高于对照组(P <.005)(138±29微米对103±微米)。(摘要截断于250字)

相似文献

1
Changes of vascular architecture independent of blood pressure in experimental uremia.实验性尿毒症中不依赖于血压的血管结构变化。
Am J Hypertens. 1995 Apr;8(4 Pt 1):409-17. doi: 10.1016/0895-7061(94)00248-a.
2
Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.实验性尿毒症中心肌内小动脉的血压非依赖性壁增厚:甲状旁腺激素许可作用的证据
Nephrol Dial Transplant. 1995 Nov;10(11):2043-8.
3
Structural remodeling of resistance arteries in uremic hypertension.尿毒症性高血压中阻力动脉的结构重塑。
Kidney Int. 2004 May;65(5):1818-25. doi: 10.1111/j.1523-1755.2004.00591.x.
4
Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.血管紧张素转换酶抑制和缓激肽拮抗对尿毒症大鼠心血管变化的影响。
Kidney Int. 2000 Jul;58(1):153-61. doi: 10.1046/j.1523-1755.2000.00163.x.
5
Reduced capillary density in the myocardium of uremic rats--a stereological study.尿毒症大鼠心肌毛细血管密度降低——一项体视学研究。
Kidney Int. 1992 Nov;42(5):1079-85. doi: 10.1038/ki.1992.390.
6
Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.内皮素受体拮抗剂影响尿毒症大鼠的心血管形态。
Kidney Int. 1999 Feb;55(2):512-9. doi: 10.1046/j.1523-1755.1999.00290.x.
7
Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells?实验性肾衰竭中的主动脉变化:平滑肌细胞的增生还是肥大?
Hypertension. 1997 Mar;29(3):770-5. doi: 10.1161/01.hyp.29.3.770.
8
Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure.dl-α-生育酚抗氧化治疗对实验性肾衰竭心血管结构的影响。
Kidney Int. 2002 Sep;62(3):877-84. doi: 10.1046/j.1523-1755.2002.00518.x.
9
Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia.可溶性鸟苷酸环化酶刺激剂BAY 41-8543及雌性性别改善轻度尿毒症大鼠模型中的尿毒症主动脉重塑。
J Hypertens. 2015 Sep;33(9):1907-20; discussion 1921. doi: 10.1097/HJH.0000000000000648.
10
Increased infarct size in uremic rats: reduced ischemia tolerance?
J Am Soc Nephrol. 2004 Jun;15(6):1530-6. doi: 10.1097/01.asn.0000130154.42061.c6.

引用本文的文献

1
Aortic stiffness after living kidney donation: a systematic review and meta-analysis.活体肾捐献后的主动脉僵硬度:一项系统评价和荟萃分析。
BMJ Open. 2024 Dec 5;14(12):e082725. doi: 10.1136/bmjopen-2023-082725.
2
Cardiovascular changes in the NZB/W F1 mouse model of lupus nephritis.狼疮性肾炎NZB/W F1小鼠模型中的心血管变化。
Front Cardiovasc Med. 2023 Jul 24;10:1182193. doi: 10.3389/fcvm.2023.1182193. eCollection 2023.
3
Cardiorenal syndrome: long road between kidney and heart.心肾综合征:肾脏与心脏之间的漫漫长路。
Heart Fail Rev. 2022 Nov;27(6):2137-2153. doi: 10.1007/s10741-022-10218-w. Epub 2022 Feb 8.
4
Cardiac Imaging in Dialysis Patients.透析患者的心脏成像
Kidney Med. 2020 Jul 31;2(5):629-638. doi: 10.1016/j.xkme.2020.05.010. eCollection 2020 Sep-Oct.
5
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.慢性肾脏损伤患者的冠状动脉微血管功能障碍、左心室重构和临床转归。
Circulation. 2020 Jan 7;141(1):21-33. doi: 10.1161/CIRCULATIONAHA.119.043916. Epub 2019 Nov 29.
6
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.尿毒症毒素的心脏毒性:心肾综合征的驱动因素。
Toxins (Basel). 2018 Sep 1;10(9):352. doi: 10.3390/toxins10090352.
7
Prognostic value of left ventricular dyssynchrony evaluated by gated myocardial perfusion imaging in patients with chronic kidney disease and normal perfusion defect scores.门控心肌灌注显像评估慢性肾脏病且灌注缺损评分正常患者左心室不同步的预后价值
J Nucl Cardiol. 2019 Feb;26(1):288-297. doi: 10.1007/s12350-017-0889-9. Epub 2017 Apr 21.
8
Thallium-201 washout rate of stress myocardial perfusion imaging as a predictor of mortality in diabetic kidney disease patients initiating hemodialysis: an observational, follow-up study.应激心肌灌注显像中铊-201洗脱率作为开始血液透析的糖尿病肾病患者死亡率预测指标的观察性随访研究
Clin Exp Nephrol. 2018 Feb;22(1):142-150. doi: 10.1007/s10157-017-1414-9. Epub 2017 Apr 21.
9
ß-2 microglobulin level is negatively associated with global left ventricular longitudinal peak systolic strain and left atrial volume index in patients with chronic kidney disease not on dialysis.在未接受透析治疗的慢性肾脏病患者中,β2微球蛋白水平与左心室整体纵向收缩期峰值应变及左心房容积指数呈负相关。
Anatol J Cardiol. 2016 Nov;16(11):844-849. doi: 10.14744/AnatolJCardiol.2015.6691. Epub 2016 Mar 23.
10
The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions.供体和受体肾功能不全对心脏移植存活的影响:对肾心相互作用的见解。
J Card Fail. 2016 May;22(5):368-75. doi: 10.1016/j.cardfail.2015.11.009. Epub 2015 Nov 23.